TLR7 and breast cancer: Although pDC infiltration is associated with poor outcomes in human breast cancer, pDC can induce tumor regression through type I IFN-mediated mechanism following intratumoral injection of TLR7 ligand in orthotopic murine mammary tumor model [39].